PK (Prabhakar K) Jadhav

Questioner
DISC Type : c

Senior Vice President - Drug Discovery at Enveda

Carlsbad, California, United States

Overview

PK (Prabhakar K) Jadhav is a highly accomplished drug discovery veteran and the Senior Vice President at Enved. With a distinguished career at Eli Lilly and DuPont, he has contributed to 18 clinical candidates, leveraging his deep expertise in medicinal chemistry. He completed a Postdoctoral Fellowship at Purdue University with a Nobel laureate.

He is a prolific inventor and author, being named on 39 patents and having published 91 papers in peer-reviewed journals.

Personality Overview

Value Seeker

Price-Sensitive

Cautious & Analytical

It is quite likely of them to ask for pricing or other concessions.  They generally do not appreciate an overfriendly approach and prefer to stay to-the-point. While they don't hesitate to ask questions, they are generally risk-averse and tend to be late adopters.

Topics They Care About

Drug Discovery
His entire career is focused on this, with specific responsibilities in lead generation, optimization, and candidate selection for various diseases like atherosclerosis and cancer.
Medicinal Chemistry
A core skill mentioned across his roles, with deep experience in structure-based drug design and heterocyclic chemistry to create novel compounds.
Clinical Candidates
A key accomplishment is his contribution to bringing 18 molecules to the clinical candidate stage, demonstrating a focus on tangible, trial-ready results.

Media Appearances

PK Jadhav - SVP, Discovery Chemistry at Enveda Biosciences | The Org. Featured in The Org

See Now

Enveda Biosciences Adds Drug Development Leaders to Scale Efforts and Accelerate Progress. Featured in Business Wire

See Now

Work History

10-2024
Senior Vice President - Drug Discovery at Enveda
8-2022 - 12-2024
Senior Vice President - Discovery Chemistry at Enveda
5-2018 - 7-2022
Co-Founder, Senior Vice President of Medicinal Chemistry & Head of Chemistry at Minghui Pharmaceutical (Shanghai) Ltd
1-2001 - 12-2017
Senior Research Fellow-Retired from Lilly as of December 31, 2017 at Eli Lilly and Company
9-1990 - 12-2000
Director at DuPont Merck and The DuPont Pharmaceuticals Company

Education

Postdoctoral Fellowship with Late Prof. Herbert C. Brown from Purdue University
Bachelor of Science - BS from University of Bombay

More Information

Social Presence :

Prographics :

Exp : 35 Location : Carlsbad, California, United States Job Level : Leadership Designation : Senior Vice President - Drug Discovery at Enveda
URL has been copied!

Insights For Selling To PK (Prabhakar K)

During A Call Or A Meeting

DO's

  • Back up any claims with data and numbers
  • Share as much information as possible regarding your product
  • Keep some extra margin in hand as they will likely negotiate the pricing

DONT's

  • Don’t depend too much on anecdotal evidence, it reduces their confidence
  • Don’t try to be too friendly or informal with them
  • Don’t overhype the product/pitch, keep it measured

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with PK (Prabhakar K) is

  • Ensuring that the product delivers ROI, cost-effective pricing and process compliance are very important for them.
  • Will you ever get a clear answer from PK (Prabhakar K)

  • It doesn’t come naturally to them but they can say no if they are not convinced.

Insights For Deal Planning

    How fast (or slow) will PK (Prabhakar K) move?

  • If they have the information that they need, they can move fast at making their decisions.
  • Can PK (Prabhakar K) take some risk or not?

  • They can take risk if they are convinced that they have analyzed the circumstances well.


You And PK (Prabhakar K)

Personality Compatibility


Other Enveda Employees

Explore more public profiles from related professionals at the same organization.

More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.